FI105685B - Menetelmä uusien terapeuttisesti käyttökelpoisten 5-substituoitujen trans-1-piperatsinoindaanijohdannaisten ja niiden farmaseuttisesti hyväksyttävien happoadditiosuolojen valmistamiseksi - Google Patents
Menetelmä uusien terapeuttisesti käyttökelpoisten 5-substituoitujen trans-1-piperatsinoindaanijohdannaisten ja niiden farmaseuttisesti hyväksyttävien happoadditiosuolojen valmistamiseksi Download PDFInfo
- Publication number
- FI105685B FI105685B FI932541A FI932541A FI105685B FI 105685 B FI105685 B FI 105685B FI 932541 A FI932541 A FI 932541A FI 932541 A FI932541 A FI 932541A FI 105685 B FI105685 B FI 105685B
- Authority
- FI
- Finland
- Prior art keywords
- compound
- trans
- dihydro
- formula
- fluorophenyl
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/30—Oxygen or sulfur atoms
- C07D233/42—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/26—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/06—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D239/08—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms directly attached in position 2
- C07D239/10—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
- C07D263/22—Oxygen atoms attached in position 2 with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to other ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
- C07D295/073—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Fats And Perfumes (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK286990A DK286990D0 (da) | 1990-12-04 | 1990-12-04 | Indanderivater |
| DK286990 | 1990-12-04 | ||
| PCT/DK1991/000358 WO1992010192A1 (en) | 1990-12-04 | 1991-11-28 | Indan derivatives |
| DK9100358 | 1991-11-28 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI932541A0 FI932541A0 (fi) | 1993-06-03 |
| FI932541A FI932541A (fi) | 1993-07-23 |
| FI105685B true FI105685B (fi) | 2000-09-29 |
Family
ID=8116621
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI932541A FI105685B (fi) | 1990-12-04 | 1993-06-03 | Menetelmä uusien terapeuttisesti käyttökelpoisten 5-substituoitujen trans-1-piperatsinoindaanijohdannaisten ja niiden farmaseuttisesti hyväksyttävien happoadditiosuolojen valmistamiseksi |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP0560868B1 (no) |
| JP (1) | JP3245418B2 (no) |
| KR (1) | KR930702980A (no) |
| AT (1) | ATE121294T1 (no) |
| AU (1) | AU653375B2 (no) |
| CA (1) | CA2097715C (no) |
| DE (1) | DE69109132T2 (no) |
| DK (2) | DK286990D0 (no) |
| ES (1) | ES2071479T3 (no) |
| FI (1) | FI105685B (no) |
| HK (1) | HK122995A (no) |
| IE (1) | IE914076A1 (no) |
| IL (1) | IL100164A (no) |
| NO (1) | NO179947C (no) |
| NZ (1) | NZ240734A (no) |
| PT (1) | PT99673B (no) |
| WO (1) | WO1992010192A1 (no) |
| ZA (1) | ZA919563B (no) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ243065A (en) * | 1991-06-13 | 1995-07-26 | Lundbeck & Co As H | Piperidine derivatives and pharmaceutical compositions |
| DK55192D0 (da) * | 1992-04-28 | 1992-04-28 | Lundbeck & Co As H | 1-piperazino-1,2-dihydroindenderivater |
| DK78692D0 (da) * | 1992-06-12 | 1992-06-12 | Lundbeck & Co As H | Dimere piperidin- og piperazinderivater |
| SK94393A3 (en) * | 1992-09-11 | 1994-08-10 | Thomae Gmbh Dr K | Cyclic derivatives of urea, process for their production and their pharmaceutical agents with the content of those |
| NZ333322A (en) * | 1996-07-01 | 2000-06-23 | Schering Corp | Di-N-substituted piperazines and 1,4-di-substituted piperidines as muscarinic antagonists |
| US5935958A (en) * | 1996-07-01 | 1999-08-10 | Schering Corporation | Muscarinic antagonists |
| TWI242011B (en) | 1997-03-31 | 2005-10-21 | Eisai Co Ltd | 1,4-substituted cyclic amine derivatives |
| IS7282A (is) * | 2001-12-21 | 2004-05-21 | H. Lundbeck A/S | Amínóindan afleiður sem serótónín og noradrenalínupptökuhindrar |
| IL162308A0 (en) * | 2001-12-21 | 2005-11-20 | Lundbeck & Co As H | Aminoindane derivatives as serotonin and norepinephrine uptakeinhibitors |
| FR2883876B1 (fr) * | 2005-03-30 | 2007-05-04 | Servier Lab | Derives d'indanyl-piperazines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| TW200819426A (en) | 2006-08-31 | 2008-05-01 | Lundbeck & Co As H | Novel indane compounds |
| JP5668177B2 (ja) | 2011-06-20 | 2015-02-12 | ハー・ルンドベック・アクチエゼルスカベット | 統合失調症の治療のための重水素化１−ピペラジノ−３−フェニルインダン |
| US11535600B2 (en) | 2018-12-03 | 2022-12-27 | H. Lundbeck A/S | Prodrugs of 4-((1R,3S)-6-chloro-3-phenyl-2,3-dihydro-1H-inden-1-yl)-1,2,2-trimethylpiperazine and 4-((1R,3S)-6-chloro-3-(phenyl-d5)-2,3-dihydro-1H-inden-1-yl)-2,2-dimethyl-1-(methyl-d3)piperazine |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE50867B1 (en) * | 1980-02-29 | 1986-08-06 | Kefalas As | Indane derivatives |
| GB8427125D0 (en) * | 1984-10-26 | 1984-12-05 | Lundbeck & Co As H | Organic compounds |
-
1990
- 1990-12-04 DK DK286990A patent/DK286990D0/da not_active Application Discontinuation
-
1991
- 1991-11-22 IE IE407691A patent/IE914076A1/en not_active IP Right Cessation
- 1991-11-26 NZ NZ240734A patent/NZ240734A/en not_active IP Right Cessation
- 1991-11-27 IL IL10016491A patent/IL100164A/en not_active IP Right Cessation
- 1991-11-28 DE DE69109132T patent/DE69109132T2/de not_active Expired - Fee Related
- 1991-11-28 DK DK92900941.3T patent/DK0560868T3/da active
- 1991-11-28 CA CA002097715A patent/CA2097715C/en not_active Expired - Fee Related
- 1991-11-28 KR KR1019930701680A patent/KR930702980A/ko not_active Application Discontinuation
- 1991-11-28 ES ES92900941T patent/ES2071479T3/es not_active Expired - Lifetime
- 1991-11-28 WO PCT/DK1991/000358 patent/WO1992010192A1/en active IP Right Grant
- 1991-11-28 AT AT92900941T patent/ATE121294T1/de not_active IP Right Cessation
- 1991-11-28 AU AU89599/91A patent/AU653375B2/en not_active Ceased
- 1991-11-28 EP EP92900941A patent/EP0560868B1/en not_active Expired - Lifetime
- 1991-11-28 JP JP50028192A patent/JP3245418B2/ja not_active Expired - Fee Related
- 1991-12-03 PT PT99673A patent/PT99673B/pt not_active IP Right Cessation
- 1991-12-04 ZA ZA919563A patent/ZA919563B/xx unknown
-
1993
- 1993-06-03 FI FI932541A patent/FI105685B/fi active
- 1993-06-03 NO NO932024A patent/NO179947C/no not_active IP Right Cessation
-
1995
- 1995-07-27 HK HK122995A patent/HK122995A/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| NO932024D0 (no) | 1993-06-03 |
| FI932541A0 (fi) | 1993-06-03 |
| CA2097715C (en) | 2003-04-15 |
| NO932024L (no) | 1993-07-30 |
| DK0560868T3 (da) | 1995-10-02 |
| JP3245418B2 (ja) | 2002-01-15 |
| EP0560868B1 (en) | 1995-04-19 |
| PT99673B (pt) | 1999-05-31 |
| IE914076A1 (en) | 1992-06-17 |
| DE69109132T2 (de) | 1995-08-31 |
| ES2071479T3 (es) | 1995-06-16 |
| WO1992010192A1 (en) | 1992-06-25 |
| HK122995A (en) | 1995-08-04 |
| NO179947B (no) | 1996-10-07 |
| IL100164A (en) | 1996-06-18 |
| DK286990D0 (da) | 1990-12-04 |
| NO179947C (no) | 1997-01-15 |
| NZ240734A (en) | 1994-02-25 |
| EP0560868A1 (en) | 1993-09-22 |
| ZA919563B (en) | 1992-08-26 |
| CA2097715A1 (en) | 1992-06-05 |
| AU653375B2 (en) | 1994-09-29 |
| PT99673A (pt) | 1992-10-30 |
| JPH06503073A (ja) | 1994-04-07 |
| FI932541A (fi) | 1993-07-23 |
| DE69109132D1 (de) | 1995-05-24 |
| ATE121294T1 (de) | 1995-05-15 |
| AU8959991A (en) | 1992-07-08 |
| KR930702980A (ko) | 1993-11-29 |
| IL100164A0 (en) | 1992-08-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3057109B2 (ja) | 新規インドール誘導体 | |
| EP1960368B1 (en) | 2,4,5-triphenyl imidazoline derivatives as inhibitors of the interaction between p53 and mdm2 proteins for use as anticancer agents | |
| FI105685B (fi) | Menetelmä uusien terapeuttisesti käyttökelpoisten 5-substituoitujen trans-1-piperatsinoindaanijohdannaisten ja niiden farmaseuttisesti hyväksyttävien happoadditiosuolojen valmistamiseksi | |
| FI84478C (fi) | Foerfarande foer framstaellning av antipsykotiska 1-fluorfenylbutyl-4-(2-pyrimidinyl)piperazinderivat. | |
| SK279292B6 (sk) | Benzimidazolové deriváty 5-ht1a a 5-ht2 antagonist | |
| SK76195A3 (en) | Condensed benzocompounds, pharmaceutical preparation containing them and their use | |
| NZ253121A (en) | N-heterocyclyl(alkyl) substituted 3-azabicyclo-[3.2.0]heptane derivatives and pharmaceutical compositions thereof | |
| JP3898219B2 (ja) | フエニルインドール化合物 | |
| EP0060610B1 (en) | Hexahydro-trans- and tetrahydropyridoindole neuroleptic agents | |
| NO300775B1 (no) | Trisykliske triazolderivater samt farmasöytisk middel inneholdende disse | |
| EP0444924B1 (en) | Fused 7-membered cyclic compound and antipsychotic preparation containing the same | |
| HU199455B (en) | Process for producing diazinylpiperidine derivatives of cyclic amides and imides | |
| US4432978A (en) | Hexahydro-trans-pyridoindole | |
| US5643784A (en) | Indan derivatives | |
| US6288230B1 (en) | 2-(2, 3-dihydrobenzofuran-5-yl)-4-aminomethylimidazoles: dopamine receptor subtype specific ligands | |
| WO2013001498A1 (en) | Amidoalkylpiperazinyl derivatives for the treatment of central nervous system diseases | |
| US4427679A (en) | Hexahydro-trans- and tetrahydropyridoindole neuroleptic agents | |
| JPH06179669A (ja) | 新規アミノアルキルクロモン、その製造方法及びそれを含む薬学的組成物 | |
| US4431649A (en) | Hexahydro-trans- and tetrahydropyridoindole neuroleptic agents | |
| US6458821B1 (en) | N-substituted azabicycloheptane derivatives, production and use thereof | |
| US7371769B2 (en) | Tetrahydropyridin-4-yl indoles with a combination of affinity for dopamine-D2 receptors and serotonin reuptake sites | |
| US4431646A (en) | Hexahydro-trans- and tetrahydropyridoindole neuroleptic agents | |
| WO2000018763A2 (en) | 2-(2,3-dihydrobenzofuran-5-yl)-4-aminomethylimidazoles: dopamine receptor subtype specific ligands |